Gastrointestinal ALK-positive anaplastic large cell lymphoma: a clinicopathological analysis of five cases.
10.3760/cma.j.cn112151-20230509-00322
- VernacularTitle:胃肠道ALK阳性间变性大细胞淋巴瘤5例临床病理学分析
- Author:
L CHEN
1
;
Z Y KE
1
;
S J YANG
1
Author Information
1. Department of Pathology, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, China.
- Publication Type:Journal Article
- MeSH:
Male;
Female;
Humans;
Lymphoma, Large-Cell, Anaplastic/pathology*;
Receptor Protein-Tyrosine Kinases/genetics*;
Anaplastic Lymphoma Kinase;
Gastrointestinal Tract/pathology*;
Lymphoma, Large B-Cell, Diffuse/genetics*
- From:
Chinese Journal of Pathology
2023;52(8):785-790
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinicpathological characteristics of ALK-positive anaplastic large cell lymphoma (ALCL) of the gastrointestinal tract, and to discuss its diagnosis and differential diagnosis. Methods: Five cases of gastrointestinal ALK-positive ALCL diagnosed and treated in Xijing Hospital of the Fourth Military Medical University, between 2011 and 2019 were collected. There were three male and two female patients, aged 5-42 years (mean 25 years). These patients clinically presented with fever and night sweats, weight loss, abdominal pain, abdominal mass, ulcers, bleeding, or intestinal obstruction, and underwent surgical resection of the tumors or endoscopic biopsy. The clinical manifestations, auxiliary examinations, histopathological characteristics, immunophenotypes and genetic alterations were analyzed. Results: In this cohort, one case was common type, two cases were monomorphic variant of common type, and two cases were small cell variant. The tumor cells in all cases expressed ALK, CD30, and one or more T lymphocyte markers, while all the markers of B lymphocyte and plasmacyte were negative. Clonality analysis showed that two cases had clonal T cell receptor (TCR) and immunoglobulin (Ig) gene rearrangement, one case had no clonal TCR but Ig gene rearrangement, and one case had no clonal TCR and Ig gene rearrangements. During the 4 to 67 months' follow-up, two patients died of the disease, two were alive with free of disease and one had a relapse. Conclusions: ALK-positive ALCL of the gastrointestinal tract is extremely rare, and has poor prognosis. Lymphoma originating from this site with CD30 and ALK-positive phenotypes may be considered to be ALCL; however differentiation from other tumors that had anaplastic features, expressed CD30 and or ALK, in particular, ALK positive large B-cell lymphoma is necessary.
